Screener
Amylyx Pharmaceuticals, Inc. AMLX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $49,326 | $226,651 |
| Marketable securities | 201,434 | 90,328 |
| Prepaid expenses and other current assets | 5,578 | 6,692 |
| Total current assets | 256,338 | 323,671 |
| Property and equipment, net | 199 | 310 |
| Restricted cash equivalents | 986 | 985 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s short-term investments?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported short-term investments of $201.43M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s short-term investments increased by 64.1% year-over-year, from $122.74M to $201.43M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s short-term investments has grown at a 18.4% compound annual growth rate (CAGR), from $45.93M to $90.33M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude